$4.00
0.16 (+4.17%)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
RSS Headlines
Fool UK